Company / Tangible Book Value per Share
PTC Therapeutics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$3.70
FY2025
5-year range
-$15.59 / $7.34
FY2021-FY2025
Trend
+76.3%
vs FY2024
Sector context
#198 of 209
Health Care
What the data says
Among 209 Health Care companies, PTC Therapeutics, Inc. is in the bottom 5% for tangible book value per share. Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $-3.70.
Based on SEC 10-K filings.
-3.70 in FY2025.
Improved from $-12.32 to $-3.70 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 209This company -$3.70 Sector average $119.74
▼
-103.1% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 76.3% year-over-year.
- Ranks #198 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.70 | +76.3% |
| FY2024 | -$15.59 | -26.5% |
| FY2023 | -$12.32 | -318.4% |
| FY2022 | $5.64 | -23.2% |
| FY2021 | $7.34 | +69.5% |
| FY2020 | $4.33 | -50.2% |
| FY2019 | $8.70 | +34.9% |
| FY2018 | $6.45 | +40.9% |
| FY2017 | $4.58 | +29.9% |
| FY2016 | $3.53 | -48.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026